FOXA2 and metastatic malignant neoplasm in the lymph nodes: The results of the multivariate analysis showed that FoxA2 expression (low vs high, HR2.772, 95% CI 1.573-4.886, p <0.001), positive surgical margins (HR = 6.1, 95% CI 2.145-17.347, p = 0.001), lymph node metastasis (HR = 2.207, 95% CI 1.550-4.454, p = 0.001), satellite lesions (HR = 2.368, 95% CI 1.296-4.328, p = 0.005), and ALB (HR = 0.933, 95% CI 0.892-0.933, P = 0.002) were associated with tumor relapse (Table 2).